RNCOS

US Proton Therapy Market Analysis to 2017

Press release   •   Aug 26, 2013 14:52 IST

According to most Oncologists, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology for radiation therapy, a majority of these patients suffer from side effects of traditional radiation treatment. Currently prevalent radio therapy methods like X-Ray/IMRT etc. also cost pretty high in the long run.

In this context, Proton Therapy, the latest innovation in the field of radio-oncology, answers all the problems related to radiation therapy. The technology is expected to eventually replace the traditional methods of radiotherapy in the future and thus, holds immense market potential for players in the industry.

The report, “US Proton Therapy Market Analysis to 2017”, presented in 30 slides, provides an extensive research and in-depth analysis of the current status and future outlook of the US proton therapy market. A thorough analysis has been carried on the various parameters concerned with the existing and upcoming proton therapy centers in the US. The report offers state-wise potential for the industry players and provides conservative market estimates till 2017.

As per our research, Procure is the leading service provider and accounts for the major chunk of proton therapy market in the US. From an equipment provider’s perspective, IBA has the maximum proton accelerators installed in the facilities. The report further delves into the anticipated transformation into competitive landscape due to increase in number of players leading to highly competitive market. It also comes up with upcoming trends, such as kind of treatment room model, types of proton accelerators being installed, etc.

With core statistical information on proton therapy market, the research also provides a glimpse on the fundamental requirements for setting up a proton therapy center. It describes in detail about the different components and their role in proton therapy. The research also portrays the amount of investment required for establishing a proton therapy center based on different treatment room models.

The report, which is a result of comprehensive analysis of the market by RNCOS experts, clearly describes various aspects related to setting up a proton therapy center and also states the appropriate location for the same. Further, all important aspects of market like the current market size, forecasts, readymade account of all the players that are expected to enter the market along with various drivers, challenges, and trends are provided, making it a must read for Consultants and Companies in/planning to get in the market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM465.htm

Some of our Related Reports are:

- Saudi Arabian Healthcare Outlook to 2017 (http://www.rncos.com/Report/IM611.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
- Global Insulin Delivery Devices Market Forecast to 2017 (http://www.rncos.com/Report/IM494.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.